Ono eyes dosing benefits in Bial opicapone deal

The news in a nutshell

The news in a nutshell

Ono Pharmaceutical has acquired exclusive rights in Japan to develop and commercialize Bial's Parkinson's disease candidate opicapone (BIA 9-1067), marking...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapeutic Category